Individual differences in dopamine-related traits influence mood effects of dopamine D2-antagonist and antidepressant treatment expectations
This study demonstrates that dopamine-related individual differences moderate the effects of both sulpiride and a placebo intervention on positive affective state. Significance Statement In one of the first pharmacological studies examining the effects of treatment expectations and dopamine on mood in a large, healthy sample, we observed that lower baseline positive affectivity was linked to stronger mood-elevating treatment responses to both a placebo and a dopamine-related drug over time. This highlights how individual differences in relevant traits can influence treatment effectiveness, offering valuable insights for tailoring personalized approaches to depression care.
Authors
- Li-Ching Chuang
- Philipp Bierwirth (ORCID: https://orcid.org/0000-0002-8420-6481)
- Erik M. Mueller (ORCID: https://orcid.org/0000-0002-8721-8963)
- Dominik Endres (ORCID: https://orcid.org/0000-0001-9756-9655)
- Diego A. Pizzagalli (ORCID: https://orcid.org/0000-0002-7772-1143)
- Ty Lees (ORCID: https://orcid.org/0000-0002-7321-2704)
- Nick Augustat
Institutions
- Boston Medical Center (US)
- Harvard University (US)
- Philipps University of Marburg (DE)
- McLean Hospital (US)
Publication Details
- Journal
- The International Journal of Neuropsychopharmacology
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1093/ijnp/pyaf067
- Citations
- 1
- Primary Topic
- Pain Management and Placebo Effect
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Deutsche Forschungsgemeinschaft
- National Institute of Mental Health